Melinda Lantz, MD, Assumes Leadership Role
Members of the American Association of Geriatric Psychiatry (AAGP) have elected Mount Sinai Beth Israel physician Melinda Lantz, MD, to become the organization’s President. Dr. Lantz, Vice Chair, Chief of Geriatric Psychiatry, and Associate Professor of...
Celebrating Trailblazer Pamela Sklar, MD, PhD
Luminaries in the study of psychiatric genomics joined the Mount Sinai community in celebrating the work of the late Pamela Sklar, MD, PhD, a groundbreaking psychiatrist and neuroscientist who made major discoveries that established the genetic roots of...
Five Specialists in the Field of Psychotic Illnesses Join Mount Sinai’s Department of Psychiatry
The recent recruitment of five specialists to the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai has revitalized research, treatment, and prevention efforts in the field of psychotic illnesses and has led to the creation of the Critical...
Addiction Institute to Explore Effective Therapies
The Icahn School of Medicine at Mount Sinai recently opened a new Addiction Institute that will address one of the nation’s greatest health concerns by exploring effective treatments for patients with substance abuse problems. “Bringing science to bear on the...
Why Marijuana Has the Potential to Treat Opioid Addiction
Yasmin Hurd, PhD, a professor of psychiatry, neuroscience, and pharmacology and systems therapeutics at the Icahn School of Medicine at Mount Sinai, discusses her new report on marijuana, and its potential to curb opioid addiction. Watch the video See more Mount Sinai...
Two Prominent Researchers in Brain Disease Assume Key Leadership Roles at Mount Sinai
Two world-renowned researchers in brain disease have assumed key leadership roles at the Icahn School of Medicine at Mount Sinai: René S. Kahn, MD, PhD, as Chair of the Department of Psychiatry, and Paul Kenny, PhD, as Chair of the Department of Neuroscience. Both men...